Codes / ICD10CM / C85.21

C85.21 Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck
  • C85.21

Summary

Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck, is a subtype of non-Hodgkin lymphoma (NHL) that originates in the mediastinum, specifically involving the thymus and lymph nodes of the head, face, and neck. It is characterized by the abnormal growth of large B lymphocytes. This condition is part of the broader NHL category and typically presents with localized involvement in the chest and upper neck regions.

Causes

The exact cause of mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck, is often unknown but involves genetic mutations in B lymphocytes. Factors such as viral infections or immune system dysregulation may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

  • Advanced age (more common in young adults)
  • Weakened immune system (e.g., immunosuppressive therapy)
  • Certain infections (e.g., Epstein-Barr virus)
  • Exposure to chemicals (e.g., pesticides, herbicides)
  • Family history of lymphoma
  • Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

  • Swollen lymph nodes in the chest (mediastinal mass) and neck/head region
  • Persistent cough or chest pain
  • Shortness of breath
  • Fever, night sweats, or unexplained weight loss
  • Fatigue or weakness
  • Difficulty swallowing

Diagnosis

Diagnosis typically involves a combination of imaging studies (e.g., CT or PET scans) to identify lymph node involvement, followed by a biopsy of the affected tissue to confirm the presence of large B-cell lymphoma. Blood tests and bone marrow aspiration may also be performed to assess disease spread.

Treatment Options

Treatment may include chemotherapy, immunotherapy, radiation therapy, or a combination of these approaches, depending on the stage and extent of the disease. Targeted therapies or stem cell transplantation may be considered for advanced cases.

Prognosis and Follow-Up

Prognosis varies based on factors such as disease stage, response to treatment, and overall health. Regular follow-up with imaging and clinical evaluations is essential to monitor for recurrence or progression.

Complications

Potential complications include respiratory distress from mediastinal mass effects, infection due to immunosuppression, and treatment-related side effects such as organ toxicity or secondary malignancies.

Lifestyle & Prevention

Maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known carcinogens may help reduce risk. Prompt treatment of infections and managing autoimmune conditions can also support overall health.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or difficulty breathing, as these may indicate lymphoma or other serious conditions.

Tips for Medical Coders

When coding C85.21, ensure documentation specifies the involvement of mediastinal (thymic) large B-cell lymphoma in the lymph nodes of the head, face, and neck. Verify that the diagnosis aligns with the anatomical site and histological type to support accurate code assignment.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C85.21 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.